Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,503 | 10 | 86.7% |
| Consulting Fee | $4,703 | 5 | 6.7% |
| Food and Beverage | $2,530 | 136 | 3.6% |
| Travel and Lodging | $1,870 | 7 | 2.7% |
| Education | $194.45 | 14 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mission Pharmacal Company | $60,924 | 15 | $0 (2018) |
| GlaxoSmithKline, LLC. | $2,153 | 3 | $0 (2022) |
| Lupin Inc. | $2,014 | 7 | $0 (2018) |
| Mitsubishi Tanabe Pharma Development America, Inc. | $1,119 | 9 | $0 (2017) |
| SCYNEXIS, Inc. | $1,050 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $775.29 | 12 | $0 (2019) |
| Allergan, Inc. | $530.39 | 21 | $0 (2020) |
| PFIZER INC. | $389.11 | 46 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $188.60 | 13 | $0 (2019) |
| AbbVie Inc. | $118.90 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,838 | 3 | GlaxoSmithKline, LLC. ($1,788) |
| 2021 | $365.00 | 1 | GlaxoSmithKline, LLC. ($365.00) |
| 2020 | $93.12 | 7 | Allergan, Inc. ($22.97) |
| 2019 | $408.52 | 30 | PFIZER INC. ($61.73) |
| 2018 | $44,799 | 57 | Mission Pharmacal Company ($42,232) |
| 2017 | $21,297 | 74 | Mission Pharmacal Company ($18,692) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 07/26/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| 03/28/2022 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 08/03/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $365.00 | General |
| 01/29/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: WOMENS HEALTH | ||||||
| 01/28/2020 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Oral Contraceptive | ||||||
| 01/27/2020 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: WOMENS HEALTH | ||||||
| 01/23/2020 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 01/15/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 01/07/2020 | Allergan, Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: WOMENS HEALTH | ||||||
| 01/07/2020 | Allergan, Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: WOMENS HEALTH | ||||||
| 12/18/2019 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Women's Health | ||||||
| 12/16/2019 | TherapeuticsMD, Inc. | BIJUVA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 12/09/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: WOMENS HEALTH | ||||||
| 11/26/2019 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Women's Health | ||||||
| 11/20/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Endocrinology | ||||||
| 11/11/2019 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: WOMENS HEALTH | ||||||
| 10/30/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.60 | General |
| 10/21/2019 | Exeltis, USA Inc. | Slynd (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: oral contraceptive | ||||||
| 10/21/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: WOMENS HEALTH | ||||||
| 10/15/2019 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Women's Health | ||||||
| 10/14/2019 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 09/18/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Endocrinology | ||||||
| 08/21/2019 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Women's Health | ||||||
| 08/12/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: WOMENS HEALTH | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MPC-SHRC-002 | Mission Pharmacal Company | $59,648 | 7 |
| BAY1002670 Long term Safety vs SoC | Bayer HealthCare Pharmaceuticals Inc. | $630.42 | 2 |
| A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ULIPRISTAL ACETATE FOR THE INTERMITTENT TREATMENT OF ABNORMAL UTERINE BLEEDING ASSOCIATED WITH LEIOMYOMAS | Allergan Inc. | $225.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 65 | 76 | $19,010 | $4,891 |
| 2022 | 4 | 128 | 145 | $32,753 | $9,368 |
| 2021 | 5 | 207 | 222 | $48,728 | $14,332 |
| 2020 | 5 | 178 | 195 | $47,988 | $12,368 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 36 | $9,900 | $2,304 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $5,782 | $1,472 | 25.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 26 | 26 | $3,328 | $1,115 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 54 | $14,850 | $4,112 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $9,499 | $2,185 | 23.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 48 | 48 | $6,144 | $2,096 | 34.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 20 | 20 | $2,260 | $974.66 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 59 | $16,225 | $4,458 | 27.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 83 | 83 | $10,624 | $3,633 | 34.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 46 | 46 | $5,198 | $2,256 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $8,673 | $2,061 | 23.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $8,008 | $1,924 | 24.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 63 | $15,840 | $3,417 | 21.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $11,088 | $2,548 | 23.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 28 | $10,745 | $2,446 | 22.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 49 | 49 | $6,160 | $2,176 | 35.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 37 | 37 | $4,155 | $1,781 | 42.9% |
About Dr. Steven Sussman, M.D
Dr. Steven Sussman, M.D is a Obstetrics & Gynecology healthcare provider based in Lawrenceville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043283690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Sussman, M.D has received a total of $69,801 in payments from pharmaceutical and medical device companies, with $2,838 received in 2022. These payments were reported across 172 transactions from 27 companies. The most common payment nature is "" ($60,503).
As a Medicare-enrolled provider, Sussman has provided services to 578 Medicare beneficiaries, totaling 638 services with total Medicare billing of $40,960. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology, Obstetrics & Gynecology
- Location Lawrenceville, NJ
- Active Since 02/13/2006
- Last Updated 05/26/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1043283690
Products in Payments
- SOLOSEC (Drug) $2,014
- Non-Covered $630.42
- LO LOESTRIN FE (Drug) $216.20
- PREMARIN (Drug) $167.72
- Kyleena (Drug) $144.87
- INTRAROSA (Drug) $123.84
- PREMARIN ORALS (Drug) $98.78
- PVC (Drug) $91.24
- Orilissa (Drug) $78.09
- MAKENA (Drug) $64.76
- CitraNatal (Drug) $56.64
- Femring (Drug) $50.48
- NUVARING (Drug) $35.24
- ESTRING (Drug) $31.37
- LILETTA (Drug) $29.94
- BIJUVA (Drug) $29.00
- Alcortin A (Drug) $28.77
- DIVIGEL (Drug) $26.35
- Bonjesta (Drug) $25.72
- HARMONIC Product Family (Device) $24.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Lawrenceville
Edmund Kim, M.d, M.D
Obstetrics & Gynecology — Payments: $652,827
Daniel Small, M.d, M.D
Obstetrics & Gynecology — Payments: $21,784
Ms. Rebecca Williams, M.d, M.D
Obstetrics & Gynecology — Payments: $16,860
Dr. Kristina Gould, M.d, M.D
Obstetrics & Gynecology — Payments: $7,490
Dr. Karen Leedom, M.d, M.D
Obstetrics & Gynecology — Payments: $7,393
Dr. Melanie Watkins, Md, MD
Obstetrics & Gynecology — Payments: $6,085